ENTX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is overvalued by -2.03% compare to its pairs and should correct downwards.

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs...

Stats
Today's Volume	69 643
Average Volume	216 567
Market Cap	65.90M
EPS	$-0.0549 ( Q1 \| 2024-05-10 )
Next earnings date	( $-0.0600 ) 2024-08-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.57 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00900 (0.50%)

AADI -10.43%

ABCL 2.78%

ABCM 0.04%

ABEO 1.19%

ABIO 6.39%

ABOS 2.54%

ABSI 0.98%

ABUS -0.32%

ABVX 3.69%

ACAD -0.73%

ACER -17.95%

ACET -9.70%

ACGN 1.29%

ACHL 0.62%

ACHV 1.29%

ACIU 0.50%

ACLX 1.98%

ACRV 0.69%

ACST -2.67%

ACXP -2.60%

ADAG 6.66%

ADAP -0.60%

ADGI 0.87%

ADIL 1.77%

ADMA 2.10%

ADPT 4.62%

ADTX -2.84%

ADVM -1.72%

ADXN -3.06%

AEON -0.94%

AEZS -2.64%

AFMD 0.00%

AGEN 18.63%

AGIO -1.12%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 3.11%

AKRO 0.26%

AKTX 0.75%

AKUS 0.00%

ALBO 0.00%

ALDX -2.65%

ALEC 0.00%

ALGS -7.51%

ALKS -0.78%

ALLK -5.66%

ALLO -4.51%

ALLR 3.85%

ALNA 3.16%

ALNY -1.62%

ALPN 0.02%

ALPX 0.00%

ALRN -4.48%

ALT 4.15%

ALVR -7.27%

ALXN 0.00%

ALXO 3.34%

ALZN -0.65%

AMRN -1.84%

AMTI -3.13%

ANAB 1.05%

ANEB 3.80%

ANGN 0.00%

ANIX -7.14%

ANL -6.05%

ANNX 1.66%

ANPC -3.15%

APGE -1.50%

APGN 8.48%

APGNW 30.65%

APLM 1.30%

APLS -7.61%

APLT 1.52%

APM -5.26%

APOP 0.38%

APRE -0.49%

APTO 1.20%

APTX 3.17%

APVO -40.57%

ARAV -13.39%

ARCT -0.41%

ARDS -17.87%

ARDX 14.00%

ARGX -3.35%

ARNA 0.00%

ARPO -0.90%

ARQT -1.27%

ARTL 3.08%

ARTLW 0.00%

ARVN 2.98%

ARWR 1.17%

ASLN 4.90%

ASMB -6.03%

ASND 0.72%

ATAI 0.76%

ATHA 0.38%

ATHE 0.56%

ATHX -33.50%

ATNF 9.27%

ATOS 4.39%

ATRA 2.91%

ATXI -2.23%

ATXS -1.30%

AUPH 1.60%

AURA 3.85%

AUTL 4.50%

AVBP 6.61%

AVEO 0.00%

AVIR -2.07%

AVRO -1.41%

AVTE -0.60%

AVTX -5.53%

AVXL -1.63%

AXLA 0.00%

AXSM 0.51%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 0.52%

BCAB -6.80%

BCDA -0.34%

BCDAW 0.00%

BCEL 0.00%

BCLI -6.08%

BCRX 1.15%

BCTX 9.62%

BCTXW 1.47%

BCYC -0.15%

BDRX 2.98%

BDTX -0.85%

BEAM -2.29%

BFRA -2.91%

BGNE -2.00%

BIOR 2.37%

BIVI -10.22%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -1.37%

BLTE -1.76%

BLU 0.03%

BLUE 3.74%

BMEA -0.66%

BMRN -1.40%

BNOX 3.51%

BNTC -0.71%

BNTX -0.02%

BOLD -14.76%

BOLT 0.32%

BPMC -0.68%

BPTH 2.56%

BPTS -13.47%

BRNS 1.45%

BRTX 10.93%

BTAI 0.79%

BTTX 30.91%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI -2.44%

CABA 1.91%

CADL 5.26%

CALA 0.00%

CALC 25.71%

CALT 0.72%

CAPR 2.80%

CARA -15.27%

CARM 18.75%

CASI 12.24%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 3.79%

CCCC 0.00%

CCXI 0.00%

CDAK 0.00%

CDIO 0.37%

CDIOW 21.56%

CDMO 1.85%

CDMOP 0.04%

CDT 3.92%

CDTTW -12.92%

CDTX 6.70%

CDXC 3.02%

CDXS 2.99%

CELC 0.68%

CELU 11.79%

CELUW 0.00%

CERC -1.68%

CERE 0.96%

CERO -1.77%

CEROW 43.57%

CFRX -27.95%

CGEM 2.05%

CGEN -4.55%

CGON 4.36%

CGTX -0.60%

CHMA -6.00%

CHRS 1.76%

CINC 0.00%

CING -45.21%

CINGW 4.85%

CKPT 4.37%

CLBS -16.75%

CLDX -1.80%

CLGN -0.60%

CLLS 0.54%

CLNN -3.47%

CLNNW 3.32%

CLRB 7.30%

CLSD 1.56%

CLSN -0.68%

CLVS 0.00%

CMMB -4.26%

CMND 25.37%

CMPI 0.00%

CMPX -16.67%

CMRA 0.00%

CMRAW 33.33%

CMRX -1.47%

CNCE 0.00%

CNSP -4.82%

CNST 0.00%

CNTA 0.56%

CNTB 18.75%

CNTX -0.25%

COCP -8.63%

COEPW 0.00%

COGT -0.12%

CORT 1.34%

COYA -0.49%

CPRX 2.99%

CRBP 3.12%

CRBU -2.38%

CRDF -4.72%

CRGX 4.99%

CRIS -7.38%

CRNX 3.04%

CRSP -2.47%

CRTX 2.63%

CRVO -0.29%

CRVS -2.67%

CSBR 0.39%

CTCX 9.02%

CTIC 0.06%

CTMX -3.17%

CTNM -6.08%

CTXR -8.54%

CUE -11.43%

CVAC 1.19%

CVKD 1.82%

CWBR 0.00%

CYAD -12.96%

CYCC -4.71%

CYCCP -11.68%

CYCN 5.99%

CYT -2.27%

CYTK 0.74%

CYTO 0.00%

DARE -8.79%

DAWN -0.36%

DBTX -0.81%

DBVT -5.53%

DFFN 10.28%

DICE 0.06%

DMAC -3.28%

DNLI 1.09%

DNTH 3.85%

DOMH -1.58%

DRMA 4.37%

DRMAW 7.69%

DRNA 0.00%

DRTS 23.41%

DRTSW -8.84%

DRUG 2.32%

DSGN 0.00%

DTIL 3.29%

DYAI -6.33%

EARS -1.77%

EDIT -1.48%

EDSA -2.51%

EFTR -6.42%

EFTRW 0.00%

EIGR -9.21%

ELAB -1.48%

ELDN 1.54%

ELEV 7.57%

ELOX 12.20%

ELTX -40.35%

ELVN -0.34%

ELYM -5.58%

ENGN 5.13%

ENGNW -0.83%

ENLV -4.70%

ENOB 1.79%

ENSC -2.78%

ENTA 2.37%

ENTO 2.51%

ENTX -5.64%

ENVB 0.71%

EPIX 1.54%

EPRX 0.78%

EPZM 0.00%

EQ 3.77%

EQRX -2.09%

EQRXW 0.00%

ERAS 2.16%

ERNA 5.17%

ERYP 1.30%

ESLA 12.90%

ESLAW 0.00%

ETNB 6.23%

ETON -0.90%

ETTX 0.00%

EVAX 1.05%

EVGN -5.74%

EVLO 0.00%

EWTX 2.91%

EXAI -2.30%

EXEL -0.27%

EYEG -0.50%

EYEN -14.16%

EYPT -0.57%

FATE 0.46%

FBIO 1.79%

FBIOP 1.02%

FBLG 7.08%

FBRX -2.01%

FDMT 0.29%

FENC -0.65%

FGEN -13.37%

FHTX 0.17%

FIXX 0.77%

FMTX 0.00%

FNCH 13.22%

FOLD 0.10%

FREQ 4.76%

FRLN 0.15%

FRTX 5.56%

FSTX 0.00%

FTRE 2.01%

FULC -1.27%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT 2.73%

GANX 2.40%

GBIO -1.05%

GBT 0.01%

GDTC 5.05%

GERN -4.50%

GHRS -2.75%

GLMD 2.46%

GLPG -1.43%

GLSI 2.25%

GLTO -5.16%

GLUE 10.65%

GLYC -11.22%

GMAB -1.76%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -6.48%

GNLX -11.36%

GNPX -3.33%

GNTA -0.32%

GOSS -5.38%

GOVX -10.28%

GOVXW -20.59%

GPCR 0.33%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -12.42%

GRTX 1.33%

GTHX 1.33%

GUTS -3.61%

GXGXW 41.67%

GYRE 20.63%

HALO 1.41%

HARP 0.09%

HCWB 1.06%

HEPA -5.55%

HGEN -84.62%

HILS 5.66%

HLVX 8.15%

HOOK -8.97%

HOTH -0.79%

HOWL -2.79%

HRMY -4.16%

HRTX 2.64%

HSTO 0.00%

HUMA 2.13%

HUMAW -1.42%

IBRX -3.36%

ICCC 11.24%

ICPT 0.21%

ICU 10.16%

ICUCW 12.50%

ICVX -0.91%

IDRA -23.04%

IDYA 2.15%

IFRX 4.19%

IGMS 3.93%

IKNA -5.71%

IKT -12.32%

IMAB -1.18%

IMCR 0.33%

IMGN 0.02%

IMGO 0.00%

IMMP 7.49%

IMMX -7.04%

IMNM 1.09%

IMNN 0.87%

IMPL -27.27%

IMRA 15.96%

IMRN -3.97%

IMRX -10.49%

IMTX -1.44%

IMTXW 2.21%

IMUX 8.82%

IMV 0.00%

IMVT 1.54%

INAB -5.87%

INBX 0.78%

INCY -1.19%

INDP -7.02%

INFI -52.38%

INKT 2.06%

INM 0.19%

INMB 1.50%

INO 4.12%

INSM 0.07%

INTS 0.20%

INVA 1.23%

INZY -1.33%

IOBT -0.85%

IONS 0.91%

IOVA 0.12%

IPA 1.23%

IPHA -1.52%

IPSC 0.79%

IRON 1.62%

ISEE 0.38%

ITOS -4.26%

ITRM -4.58%

IVA -0.33%

IVVD -8.33%

JAGX -1.11%

JANX 3.84%

JAZZ -0.35%

JNCE 0.00%

JSPR 3.13%

JSPRW 5.15%

JUNS 0.00%

JUNSW 0.00%

KA -5.43%

KALV -2.24%

KDNY 0.22%

KMPH -0.34%

KNSA 0.43%

KNTE -0.38%

KOD -3.29%

KPRX 1.20%

KPTI -10.84%

KRBP 6.83%

KRON 3.33%

KROS 1.40%

KRRO 1.20%

KRTX 0.03%

KRYS 0.42%

KTRA -3.60%

KTTA 1.62%

KTTAW 0.92%

KURA 0.44%

KYMR -1.22%

KYTX 1.90%

KZIA 2.65%

KZR -5.41%

LABP 0.57%

LBPH 20.19%

LBPS 0.00%

LBPSW 14.81%

LEGN -0.83%

LENZ -2.92%

LEXX 5.70%

LEXXW -5.15%

LGND 2.34%

LGNDV 0.00%

LGVN -4.17%

LIAN -8.28%

LIFE 2.70%

LIPO -3.43%

LIXT -2.47%

LIXTW -3.71%

LJPC -0.32%

LMNL 0.12%

LOGC -2.06%

LPCN 6.32%

LPTX 10.73%

LQDA -3.07%

LRMR -1.36%

LSTA -0.57%

LTRN 2.86%

LUMO 2.20%

LVTX -3.74%

LXEO 7.94%

LXRX -3.45%

LYEL 5.07%

LYRA 5.93%

MACK 0.10%

MBIO 1.59%

MBRX -3.83%

MCRB -7.80%

MDGL -1.93%

MDNA -13.16%

MDWD 4.30%

MDXG 2.51%

MEIP -1.36%

MESO -0.58%

MGNX 3.16%

MGTA -7.74%

MGTX -0.47%

MGX 8.22%

MIRM 3.26%

MIRO 0.59%

MIST 2.33%

MITO 0.00%

MLEC 1.85%

MLECW -28.57%

MLND -5.36%

MLTX 5.47%

MLYS 1.74%

MNKD -1.32%

MNMD -0.55%

MNOV 0.00%

MNPR -1.67%

MOLN 4.33%

MOR 0.17%

MORF 0.18%

MREO 3.45%

MRKR 12.42%

MRNA -2.01%

MRNS -4.88%

MRSN 0.75%

MRTX -0.17%

MRUS -1.71%

MRVI 1.13%

MTCR -1.29%

MTEM 3.60%

MTP -18.50%

MURA 2.28%

MYMD -1.08%

NAMS -1.69%

NAMSW -3.11%

NAUT 2.63%

NBRV 0.71%

NBSE -1.56%

NBTX -10.71%

NCNA -4.49%

NERV 4.59%

NEXI 0.00%

NGM -1.28%

NGNE 4.51%

NKGN 2.42%

NKGNW -12.00%

NKTR 8.77%

NKTX 0.85%

NLSP -9.63%

NLSPW 7.48%

NMRA 6.85%

NMTR -42.97%

NOVN -24.84%

NRBO 0.83%

NRIX 0.63%

NRSN 9.80%

NRSNW 21.18%

NRXP -6.87%

NRXPW -16.53%

NRXS 4.51%

NTBL -6.32%

NTEC -12.45%

NTHI 0.00%

NTLA -3.49%

NTRBW 74.65%

NUVL -1.44%

NVAX -1.33%

NVCT 0.96%

NVIV -34.28%

NXTC -3.05%

NYMX -0.05%

OABI -0.53%

OABIW 6.37%

OBIO 2.77%

OBSV 0.00%

OCEA -11.59%

OCGN 8.39%

OCS 1.44%

OCUL 1.18%

OCUP 0.66%

ODT -4.27%

OKYO 0.85%

OLMA -3.48%

OMER 2.78%

OMGA -7.59%

ONCO -18.40%

ONCR -3.08%

ONCS 31.87%

ONCT -1.17%

ONCY -1.98%

ONTX -0.47%

ONVO -0.41%

OPNT 0.00%

OPT 3.21%

ORGS -5.36%

ORIC 2.32%

ORMP -4.10%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.73%

OVID 5.89%

OYST 0.00%

PALI -1.53%

PASG -14.04%

PBLA 11.11%

PBM -8.81%

PBYI 0.93%

PCSA 8.21%

PCVX -4.14%

PDSB -2.66%

PEPG -3.04%

PGEN 4.64%

PHAR 3.47%

PHAS 0.00%

PHAT -0.96%

PHIO 1.75%

PHIOW 36.47%

PHVS 4.39%

PHXM -5.20%

PIRS 5.83%

PKBO 0.00%

PKBOW 999 900.00%

PLRX 0.84%

PLUR 7.04%

PMN -1.96%

PMVP -2.41%

PNT 0.16%

PPBT -6.42%

PRAX 4.02%

PRDS 0.93%

PRLD 3.25%

PROG -3.47%

PROK 1.65%

PRQR 0.61%

PRTA 0.54%

PRTC 4.56%

PRTG -6.11%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -1.34%

PSTX 7.35%

PTCT -11.77%

PTE -0.82%

PTGX 8.69%

PTIXW -47.77%

PULM 0.52%

PXMD -9.45%

PYPD 3.12%

PYXS 3.12%

QLGN -3.31%

QNCX 4.87%

QNRX -2.85%

QSI 11.70%

QSIAW 4.08%

QTTB 17.70%

QURE -1.32%

RAIN -1.63%

RANI -3.55%

RAPT 5.54%

RARE -0.77%

RCKT 0.47%

REGN 0.02%

RENB 16.67%

REPL 5.63%

RETA 0.02%

REUN -0.89%

REVB 2.69%

REVBU 3.46%

REVBW 19.05%

RGLS -11.85%

RGNX 0.60%

RIGL -13.75%

RLAY 3.49%

RLMD 0.33%

RLYB -9.46%

RNA 0.76%

RNAC -5.29%

RNAZ -0.50%

RNXT -2.59%

ROIV 0.00%

ROIVW 4.56%

RPHM -6.21%

RPRX -1.12%

RPTX -2.37%

RUBY 2.70%

RVLP -32.05%

RVMD 0.73%

RVMDW 45.86%

RVNC -0.39%

RVPH 0.00%

RVPHW 1.89%

RXDX 0.09%

RXRX -0.99%

RYTM 2.32%

RYZB 0.02%

RZLT 7.23%

SABS 6.16%

SABSW 35.43%

SAGE 1.59%

SANA 1.11%

SAVA -34.83%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI -2.80%

SCPH -0.46%

SCPS 0.00%

SEEL -2.10%

SEER -4.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -10.11%

SGMT -16.79%

SGTX -2.56%

SIOX 22.63%

SLDB -1.22%

SLGL 3.37%

SLN 0.00%

SLNO -2.28%

SLRX -2.86%

SLS 4.39%

SMMT -0.89%

SNDX 1.03%

SNGX -7.19%

SNPX 0.99%

SONN -1.41%

SPPI -0.49%

SPRB -2.72%

SPRC -5.99%

SPRO -2.99%

SRNE 5.26%

SRPT 0.03%

SRRA 0.00%

SRRK -0.36%

SRZN 10.16%

STAB 0.00%

STOK 1.50%

STRO 0.34%

STSA 0.00%

STTK 2.93%

SURF -0.93%

SVRA 5.77%

SWTX 0.37%

SYBX -1.96%

SYRS -9.95%

TALS -0.73%

TARA -4.15%

TARS 7.99%

TBPH 1.80%

TCBP -1.31%

TCDA 0.00%

TCON -1.38%

TCRR 0.00%

TCRT -2.92%

TCRX -6.25%

TECH -0.24%

TENX 1.17%

TERN -4.22%

TFFP 3.11%

TGTX -0.89%

THRX 0.12%

TIL -1.06%

TLC 0.00%

TLSA 4.43%

TNGX 0.47%

TNXP 1.07%

TNYA 5.44%

TPST 0.92%

TRDA 0.56%

TRVI 1.36%

TRVN 1.40%

TSHA 3.46%

TSVT 2.39%

TTNP 0.91%

TVTX -0.72%

TYRA 3.50%

UBX -2.17%

UNCY 23.70%

URGN -1.12%

UTHR 0.51%

VACC 11.36%

VALN -5.14%

VAXX -0.24%

VBIV 1.54%

VBLT -8.77%

VCEL -2.20%

VCNX 2.69%

VCYT -1.46%

VERA 4.39%

VERU 5.16%

VERV 2.52%

VIGL -10.71%

VINC 9.46%

VIR 0.34%

VIRI -8.20%

VIRX -5.93%

VKTX 4.41%

VLON -13.04%

VNDA -2.75%

VOR -12.28%

VRCA 0.97%

VRDN 1.80%

VRNA -6.35%

VRPX -0.52%

VRTX -0.80%

VSTM 2.76%

VTGN 0.00%

VTVT -0.34%

VTYX -3.35%

VXRT 0.20%

VYGR 0.64%

VYNE 0.00%

VYNT 7.78%

WINT -3.60%

WVE 0.00%

XBIO 1.50%

XBIT 11.50%

XCUR 5.89%

XENE 4.22%

XERS -0.44%

XFOR -13.45%

XLO 0.80%

XLRN 0.00%

XNCR -1.41%

XOMA 3.45%

XOMAO 0.24%

XOMAP 0.08%

XRTX 0.00%

YMAB -2.03%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -1.08%

ZNTL -2.62%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-28	Burshtein Gregory	Sell	0	Ordinary Shares, par value NIS 0.0000769 per share
2024-05-28	Burshtein Gregory	Sell	20 000	Stock Option (right to buy)
2024-05-28	Burshtein Gregory	Sell	18 900	Stock Option (right to buy)
2024-05-28	Burshtein Gregory	Sell	51 000	Stock Option (right to buy)
2024-05-28	Burshtein Gregory	Sell	45 000	Stock Option (right to buy)

INSIDER POWER
66.92
Last 96 transactions
Buy: 4 653 836 \| Sell: 4 121 606

Correlation (AI algo v.1.1b): Overvalued: -2.03% $1.836 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.09 (neutral)

Short: -0.18 (neutral)

Signal:(40.717) Neutral

Entera Bio Ltd Correlation

10 Most Positive Correlations
PRIM	0.947
SWAV	0.947
PPC	0.946
TCOM	0.945
INCR	0.942
PNTG	0.941
XBIT	0.937
ROOT	0.934
FRLA	0.931
IVCB	0.929

10 Most Negative Correlations
SIRI	-0.94
FAIL	-0.937
JACK	-0.935
FXNC	-0.928
XPON	-0.927
TTEC	-0.927
NLSP	-0.926
PRTS	-0.925
RMGC	-0.92
HAIN	-0.92

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Entera Bio Ltd Correlation - Currency/Commodity

0.74
( moderate )

0.02
( neutral )

0.00
( neutral )

-0.51
( weak negative )

0.05
( neutral )

-0.78
( moderate negative )

Entera Bio Ltd Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2023
Revenue:	$0
Gross Profit:	$-56 000.00 (0.00 %)
EPS:	$-0.310

FY	2022
Revenue:	$134 000
Gross Profit:	$33 000.00 (24.63 %)
EPS:	$-0.450

FY	2021
Revenue:	$571 000
Gross Profit:	$198 000 (34.68 %)
EPS:	$0.425

Financial Reports:

No articles found.

Entera Bio Ltd Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Entera Bio Ltd

Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.